Medicines for Europe announces new President, launches Access to Medicines campaign

10 October 2017

The newly elected President of Medicines for Europe – Marc-Alexander Mahl – […]

Medicines for Europe to join the ISPOR Issue Panel on value added medicines

5 October 2017

Value added medicines represent a major opportunity to improve patients’ […]

Europe needs change to drive added value

15 September 2017

European report calms common concerns

15 September 2017

Value Added Medicines: Time to adjust the HTA Decision Frameworks for more patient-centric innovation

5 September 2017

A new study “Value Added Medicines: Time to Adjust the […]

Europäer zahlen zu viel für Pillen

18 July 2017

“É possível fazer os médicos portugueses prescreverem mais genéricos”

18 July 2017

Jacek Glinka: “Biossimilares podem poupar ao SNS 120 milhões de euros”

18 July 2017

Pharma expert: EU drug agency should be ‘easily’ accessible to all

18 July 2017

Latest Data Shows the Need to Promote Biosimilar and Value Added Medicines for Better Health

16 June 2017

Biosimilar medicines are transforming treatment by enabling better access to […]